Investor Presentation Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q4 & FY25 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q3 & 9M FY25 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q2 and FY25 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation made to the shareholders at the 39th AGM
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q1FY25 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation for the Quater and Year ended March 31, 2024.
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q3 & 9M FY24 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Q2 & H1 FY24 Investor Presentation
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Presentation to the shareholders at the 38th Annual General Meeting
Investor Presentation AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached herewith Q1FY24 Investor Presentation